ACR Convergence 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

AB

AMPEL BioSolutions at ACR Convergence 2026

Nov 6–11, 2026 Orlando, FL ~15k attendees Website

AMPEL BioSolutions brings 2 presentations to ACR Convergence 2026 in Orlando. Its program centres on gene-expression profiling in autoimmune disease, mapping the molecular landscape of lupus nephritis and sorting rheumatoid arthritis by response to TNF inhibitors.

OrganizationACR Convergence 2026 Attendance
AB
AMPEL BioSolutions
Biotech companies
A biotechnology company applying computational biology to autoimmune disease drug development.

Explore the full ACR Convergence 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Orlando. Leave your work email and we’ll be in touch.

Privacy

Download the full ACR Convergence 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at AMPEL BioSolutions

Tell us what you sell and we’ll find the people at AMPEL BioSolutions most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American College of Rheumatology (ACR). Organization details are derived from the ACR’s published program and exhibitor floor plan, and each organization’s own website. Submit a correction